Display options
Share it on

Ann Hepatobiliary Pancreat Surg. 2021 Nov 30;25(4):571-574. doi: 10.14701/ahbps.2021.25.4.571.

Long-term outcomes of emergency ABO-incompatible living donor liver transplantation using a modified desensitization protocol for highly sensitized patients with acute liver failure: A case report.

Annals of hepato-biliary-pancreatic surgery

Boram Lee, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Moonhwan Kim, YoungRok Choi

Affiliations

  1. Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  2. Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

PMID: 34845134 PMCID: PMC8639309 DOI: 10.14701/ahbps.2021.25.4.571

Abstract

Although there is no established desensitization protocol for liver transplantation (LT), desensitization usually entails treatment with rituximab, plasmapheresis, splenectomy, and intravenous immunoglobulin (IVIG) infusion together with a local graft. The desensitization protocol is usually initiated 2 to 3 weeks before transplantation. Therefore, patients with acute liver failure warranting urgent LT are usually ineligible for ABO-incompatible (ABOi) LT. For these reasons, several attempts have been made to abridge the desensitization protocol and extend the indication for ABOi living donor LT (LDLT). Here we report a 40-year-old female diagnosed with chronic hepatitis B and acute-on-chronic liver failure (model for end-stage liver disease score, 31). In the absence of a suitable compatible liver donor, emergency ABOi LT was planned using a modified desensitization protocol. The preoperative isoagglutinin (IA) titer was 1 : 1,024 and the preoperative T- and B-cell cross-matches were positive. The patient received a single dose of rituximab (375 mg/m

Keywords: Graft rejection; Immunoglobulins, intravenous; Liver failure, acute; Liver transplantation

References

  1. Hepatobiliary Pancreat Dis Int. 2014 Aug;13(4):395-401 - PubMed
  2. Am J Transplant. 2014 Jan;14(1):102-14 - PubMed
  3. Leukemia. 2008 Jan;22(1):179-85 - PubMed
  4. Hepatology. 2008 Jan;47(1):143-52 - PubMed
  5. Blood. 2002 Feb 1;99(3):754-8 - PubMed
  6. Liver Transpl. 2006 Mar;12(3):457-64 - PubMed
  7. Surgery. 1986 Aug;100(2):342-8 - PubMed
  8. Br J Clin Pharmacol. 2013 Nov;76(5):734-40 - PubMed
  9. Circulation. 1999 Nov 9;100(19 Suppl):II229-35 - PubMed
  10. Transplantation. 2005 Jan 15;79(1):12-6 - PubMed
  11. Am J Transplant. 2016 Jan;16(1):157-70 - PubMed
  12. Liver Int. 2018 May;38(5):932-939 - PubMed
  13. J Clin Oncol. 2003 Nov 1;21(21):3940-7 - PubMed
  14. Xenotransplantation. 2006 Mar;13(2):154-9 - PubMed
  15. Am J Transplant. 2008 Dec;8(12):2607-17 - PubMed
  16. Hepatobiliary Pancreat Dis Int. 2018 Apr;17(2):119-125 - PubMed
  17. Transplantation. 2018 Jan;102(1):97-104 - PubMed
  18. Transplant Proc. 2013 Apr;45(3):1110-5 - PubMed
  19. Ann Hepatobiliary Pancreat Surg. 2019 Aug;23(3):211-218 - PubMed

Publication Types